XML 25 R15.htm IDEA: XBRL DOCUMENT

Fair Value Measurements and Fair Value of Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2023

Fair Value Disclosures [Abstract]

Schedule of Cash Equivalents and Short-term Investments

The following is a summary of the Company’s cash equivalents and short-term investments:


			September 30, 2023
			Amortized Cost Basis						Unrealized Gains						Unrealized Losses						Estimated Fair Value
			(In thousands)
Level 1:
Money market funds			$	10,140					$	—					$	—					$	10,140
Level 2:
Commercial paper			91,259						—						(31)						91,228
U.S. government and agency securities			11,786						—						(71)						11,715

Total cash equivalents and short-term investments			113,185						—						(102)						113,083
Less: cash equivalents			(101,399)						—						32						(101,367)
Total short-term investments			$	11,786					$	—					$	(70)					$	11,716


			December 31, 2022
			Amortized Cost Basis						Unrealized Gains						Unrealized Losses						Estimated Fair Value
			(In thousands)
Level 1:
Money market funds			$	10,235					$	—					$	—					$	10,235
Level 2:
Commercial paper			102,722						—						(246)						102,476
U.S. government and agency securities			59,487						—						(824)						58,663
Corporate bonds			2,059						—						(35)						2,024

Total cash equivalents and short-term investments			174,503						—						(1,105)						173,398
Less: cash equivalents			(56,256)						—						16						(56,240)
Total short-term investments			$	118,247					$	—					$	(1,089)					$	117,158